Maternal immunity and antibodies to dengue can promote Zika virus-induced microcephaly in fetuses

Autor: Lim T, St John Al, Rathore Aps, Saron Waa, Jahan N

Publikováno v: International Journal of Infectious Diseases. 73:48

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e91869cec53b9e958606e369ad090bbf
https://doi.org/10.1016/j.ijid.2018.04.3532

Differential contributions of fetal mononuclear phagocytes to Zika virus neuroinvasion versus neuroprotection during congenital infection.

Autor: Abdelbasset M; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Saron WAA; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore., Ma D; Neuroscience & Behavioral Disorders Programme, Duke-National University of Singapore Medical School, Singapore 169857, Singapore., Rathore APS; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore; Department of Pathology, Duke University Medical Center, Durham, NC 27705, USA., Kozaki T; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Immunos, Singapore 138648, Singapore., Zhong C; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Immunos, Singapore 138648, Singapore., Mantri CK; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore., Tan Y; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Immunos, Singapore 138648, Singapore; National Skin Centre, National Healthcare Group, Singapore, Singapore., Tung CC; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore., Tey HL; National Skin Centre, National Healthcare Group, Singapore, Singapore., Chu JJH; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Infectious Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Chen J; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Immunos, Singapore 138648, Singapore., Ng LG; Shanghai Immune Therapy Institute, Shanghai Jiao Tong University School of Medicine affiliated Renji Hospital, Shanghai, China., Wang H; Neuroscience & Behavioral Disorders Programme, Duke-National University of Singapore Medical School, Singapore 169857, Singapore; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore., Ginhoux F; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), 8A Biomedical Grove, Immunos, Singapore 138648, Singapore; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., St John AL; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Pathology, Duke University Medical Center, Durham, NC 27705, USA; SingHealth Duke-NUS Global Health Institute, Singapore, Singapore. Electronic address: ashley.st.john@duke-nus.edu.sg.

Publikováno v: Cell [Cell] 2024 Nov 06. Date of Electronic Publication: 2024 Nov 06.

NKT cells promote Th1 immune bias to dengue virus that governs long-term protective antibody dynamics.

Autor: Choi Y; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore., Saron WA; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore., O'Neill A; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore., Senanayake M; Department of Paediatrics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.; Lady Ridgeway Children's Hospital, Colombo, Sri Lanka., Wilder-Smith A; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.; Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom., Rathore AP; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., St John AL; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; SingHealth Duke-NUS Global Health Institute, Singapore.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Aug 01; Vol. 134 (18). Date of Electronic Publication: 2024 Aug 01.

Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern.

Autor: O'Neill A; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore., Mantri CK; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore., Tan CW; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore; Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 117545, Singapore., Saron WAA; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore., Nagaraj SK; Centre for Infectious Disease Research, Microbiology and Cell Biology Department, Indian Institute of Science, Bengaluru, 560012, India., Kala MP; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore., Joy CM; Centre for Infectious Disease Research, Microbiology and Cell Biology Department, Indian Institute of Science, Bengaluru, 560012, India., Rathore APS; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore; Department of Pathology, Duke University Medical Centre, Durham, North Carolina, 27705, USA., Tripathi S; Centre for Infectious Disease Research, Microbiology and Cell Biology Department, Indian Institute of Science, Bengaluru, 560012, India., Wang LF; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore; SingHealth Duke-NUS Global Health Institute, Singapore., St John AL; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore; Department of Pathology, Duke University Medical Centre, Durham, North Carolina, 27705, USA; SingHealth Duke-NUS Global Health Institute, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: ashley.st.john@duke-nus.edu.sg.

Publikováno v: EBioMedicine [EBioMedicine] 2024 Jan; Vol. 99, pp. 104924. Date of Electronic Publication: 2023 Dec 18.

Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19.

Autor: Tan JY; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Anderson DE; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia., Rathore AP; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., O'Neill A; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Mantri CK; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Saron WA; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Lee CQ; Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore., Cui CW; Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore., Kang AE; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Foo R; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Kalimuddin S; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore., Low JG; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore., Ho L; Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore., Tambyah P; Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Division of Infectious Disease, University Medicine Cluster, National University Hospital, Singapore., Burke TW; Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, North Carolina, USA., Woods CW; Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Division of Infectious Diseases, Duke University Medical Center, Durham VA Medical Center, Durham, North Carolina, USA., Chan KR; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Karhausen J; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA., St John AL; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Microbiology and Immunology, National University of Singapore, Singapore.; SingHealth Duke-NUS Global Health Institute, Singapore.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2023 Oct 02; Vol. 133 (19). Date of Electronic Publication: 2023 Oct 02.